Carlos Escalante
- Molecular Biology top 5%
- Immunology top 5%
- Infectious Diseases top 5%
- Genetics top 5%
- Oncology top 10%
- Co-authors
- Aneel K. AggarwalDimitris ThanosJunming YieJosé TrincãoLouise PrakashSatya PrakashThomas A. EdwardsLeyi Shen
- Topics
- Virus-based gene therapy research (16 papers)RNA Research and Splicing (11 papers)RNA and protein synthesis mechanisms (9 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Carlos Escalante
49 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 105
- Molecular Biology 1.4k
- Immunology 853
- Infectious Diseases 537
- Genetics 465
- Oncology 441
Countries citing papers authored by Carlos Escalante
This map shows the geographic impact of Carlos Escalante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Escalante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Escalante more than expected).
Fields of papers citing papers by Carlos Escalante
This network shows the impact of papers produced by Carlos Escalante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Escalante. The network helps show where Carlos Escalante may publish in the future.
Co-authorship network of co-authors of Carlos Escalante
This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Escalante. A scholar is included among the top collaborators of Carlos Escalante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Escalante. Carlos Escalante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 22 | |
| 3 | 23 | |
| 4 | 23 | |
| 5 | 260 | |
| 6 | 25 | |
| 7 | 50 | |
| 8 | 21 | |
| 9 | 33 | |
| 10 | 173 | |
| 11 | 13 | |
| 12 | 96 | |
| 13 | 224 | |
| 14 | 126 | |
| 15 | 61 | |
| 16 | 11 | |
| 17 | 285 | |
| 18 | 338 | |
| 19 | 10 | |
| 20 | 4 |
About Carlos Escalante
Carlos Escalante is a scholar working on Genetics, Structural Biology and Infectious Diseases, having authored 49 papers that have together received 2.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (16 papers), RNA Research and Splicing (11 papers) and RNA and protein synthesis mechanisms (9 papers). The work is most often cited by research in Immunology (853 citations), Infectious Diseases (537 citations) and Immunology and Allergy (138 citations). Carlos Escalante has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Aneel K. Aggarwal, Dimitris Thanos, Junming Yie, José Trincão, Louise Prakash, Satya Prakash, Thomas A. Edwards, Leyi Shen, R. Michael Linden and R. E. Johnson. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.